checkAd

     459  0 Kommentare Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019 - Seite 3


    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019 - Seite 3 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa technology and Nf-L assays were used in many of the groundbreaking research and treatment …